KSI vs. VHI, DR, OGI, FRX, QIPT, CPH, ACB, CRDL, HLS, and SVA
Should you be buying kneat.com stock or one of its competitors? The main competitors of kneat.com include Vitalhub (VHI), Medical Facilities (DR), Organigram (OGI), Fennec Pharmaceuticals (FRX), Quipt Home Medical (QIPT), Cipher Pharmaceuticals (CPH), Aurora Cannabis (ACB), Cardiol Therapeutics (CRDL), HLS Therapeutics (HLS), and Sernova (SVA). These companies are all part of the "medical" sector.
kneat.com (TSE:KSI) and Vitalhub (TSE:VHI) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, dividends, institutional ownership, profitability, valuation and community ranking.
Vitalhub has higher revenue and earnings than kneat.com. kneat.com is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks.
kneat.com has a beta of 1, indicating that its share price has a similar volatility profile to the S&P 500.Comparatively, Vitalhub has a beta of 1.21, indicating that its share price is 21% more volatile than the S&P 500.
Vitalhub has a net margin of 8.66% compared to kneat.com's net margin of -41.26%. Vitalhub's return on equity of 5.78% beat kneat.com's return on equity.
Vitalhub received 4 more outperform votes than kneat.com when rated by MarketBeat users. However, 100.00% of users gave kneat.com an outperform vote while only 62.50% of users gave Vitalhub an outperform vote.
In the previous week, kneat.com had 1 more articles in the media than Vitalhub. MarketBeat recorded 1 mentions for kneat.com and 0 mentions for Vitalhub. kneat.com's average media sentiment score of 0.59 beat Vitalhub's score of 0.00 indicating that kneat.com is being referred to more favorably in the media.
10.4% of kneat.com shares are owned by institutional investors. Comparatively, 22.2% of Vitalhub shares are owned by institutional investors. 24.9% of kneat.com shares are owned by insiders. Comparatively, 21.1% of Vitalhub shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Vitalhub has a consensus price target of C$6.42, suggesting a potential upside of 2.67%. Given Vitalhub's higher possible upside, analysts plainly believe Vitalhub is more favorable than kneat.com.
Summary
Vitalhub beats kneat.com on 12 of the 17 factors compared between the two stocks.
Get kneat.com News Delivered to You Automatically
Sign up to receive the latest news and ratings for KSI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding KSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
kneat.com Competitors List
Related Companies and Tools
